Transcranial Magnetic Stimulation for Perinatal Depression

Main depressive dysfunction (MDD) impacts roughly 10% to fifteen% of pregnant sufferers, inflicting maternal misery, elevated threat of suicide, life-threatening obstetric problems, and lasting neurodevelopmental results on offspring.^1–4 The strongest evidence-based therapies for MDD throughout being pregnant are psychotherapy and pharmacotherapy, usually with selective serotonin reuptake inhibitors (SSRIs), however these might not at all times be viable or acceptable choices for sufferers as a consequence of symptom severity, the necessity for speedy symptom decision, and perceived considerations in regards to the results of medicines on fetal improvement.^1,5 Due to this fact, non-pharmacologic neuromodulation therapies comparable to transcranial magnetic stimulation (TMS) have gained curiosity and analysis consideration.

TMS is an FDA-approved, non-invasive, and protected neuromodulation remedy for MDD that makes use of magnetic pulses to stimulate particular areas of the mind related to psychiatric issues.⁶ Not like pharmacotherapy or different types of neuromodulation, TMS has no systemic negative effects and doesn’t induce a seizure or require anesthesia. Moreover, the electrical area generated is much under the security restrict really helpful in pregnant sufferers.⁷ TMS has additionally been safely utilized in pregnant sufferers for neurological indications.^7,8 To be taught extra about TMS click on here.

TMS for Despair Throughout Being pregnant

Though there are presently no pointers for using TMS in being pregnant, a number of latest research present promising outcomes with minimal negative effects. For research earlier than 2015 click on here. A randomized management trial of twenty-two pregnant sufferers within the second or third trimester confirmed that TMS delivered to the correct dorsolateral prefrontal cortex (DLPFC) at 1 Hz over 20 periods had greater response and remission charges in comparison with a sham group.⁹ Sufferers obtained a single prepare of 900 pulses per session at 100% motor threshold (MT) 5 occasions every week for 4 weeks. Estrogen and progesterone ranges remained steady earlier than and after TMS therapy, and there have been no main negative effects skilled by the mom or child within the therapy group.

Moreover, a number of case studies of sufferers handled with TMS through the first and second trimesters with numerous stimulation parameters have been printed. Some skilled therapy response whereas persevering with SSRIs or psychotherapy. Three sufferers skilled therapy response from TMS delivered to the left DLPFC at 10 Hz for five periods every week for 4 weeks for 3,000 pulses per session at 120% of MT.¹⁰ Two sufferers additionally responded after receiving proper DLPFC stimulation at 1 Hz for five periods every week for 4 weeks for a complete of 1,800 pulses per session at 120% of MT.^10,11 One affected person delivered twins at late preterm (36 weeks). Of word, twin pregnancies are a longtime issue related to supply earlier than time period at 37 weeks.¹²  Sufferers reported no main negative effects, obstetric problems, or congenital malformations.

Particular Issues in Being pregnant

The commonest negative effects of TMS in all affected person populations, together with being pregnant, are transient scalp ache and headache.¹³ The one pregnancy-related complication from TMS that has occurred in a couple of affected person is supine hypotensive syndrome.¹⁴ In supine hypotensive syndrome, the inferior vena cava turns into compressed by the gravid uterus when a pregnant affected person is supine, lowering venous return. To mitigate this threat, it’s suggested that sufferers over 24 weeks gestational age be positioned on their left facet utilizing a wedge cushion with not less than a 30-degree left pelvic tilt whereas receiving low-frequency right-sided TMS.¹⁴

One newer TMS protocol, theta burst stimulation (TBS), could also be a preferable choice because it reduces the chance of supine hypotension throughout therapy. TBS works by simulating hippocampal theta electroencephalography rhythms, that are thought to induce long-term plasticity in neurons.^15,16 Standard repetitive TMS (rTMS) periods last as long as 37.5 minutes, whereas intermittent TBS protocols final 3 minutes, lowering price and time burden to sufferers.¹⁷ TBS is equal to rTMS in efficacy, security, sturdiness, and tolerability, and was FDA-approved for the therapy of MDD in 2018.¹⁷ A number of circumstances of profitable therapy of MDD with TBS throughout being pregnant have been reported, with 15 sufferers safely present process therapy throughout all three trimesters.^18-21 One affected person had meconium-stained amniotic fluid, however no different obstetric or fetal problems have been famous.¹⁸

TMS within the Postpartum Interval

TMS additionally reveals promise as an efficient, protected, and sturdy therapy for postpartum despair (PPD). In a 2016 multi-center open-label research of 19 sufferers, 14 achieved remission of PPD from TMS monotherapy with no critical hostile occasions.²⁰ Sufferers on this research have been handled with TMS delivered to the left DLPFC at 10 Hz for five periods every week for 4-8 weeks. They obtained 3,000 whole pulses of TMS per session at 120% of MT. Moreover, a 2020 case collection of 6 sufferers with PPD have been handled with open-label TMS utilizing the identical parameters.²³ Of the 6 sufferers, 2 sufferers’ despair responded to TMS, and 4 reached remission, which was sustained at 6-month follow-up. There have been no main negative effects together with results on lactation.

Future Instructions

TMS in being pregnant and the postpartum interval seems to be a promising therapy choice with no studies of hostile obstetric outcomes or congenital malformations. Nevertheless, nearly all of the information presently accessible consists of case studies, and a single randomized managed trial that yielded encouraging outcomes however was restricted by a small pattern dimension. Recruitment of sufferers for research on TMS could also be difficult, as many are usually not conversant in the therapy. Prior research have demonstrated that offering sufferers with informational movies about TMS can enhance their information and willingness to pursue the therapy.²⁴

Limitations of the present literature embody variations in therapy parameters comparable to excessive versus low frequency, proper versus left stimulation, trimester of publicity, and normal rTMS versus TBS. Future analysis may deal with successfully figuring out sufferers who might profit from TMS and educating them in regards to the therapy. To additional help the outcomes of the 2019 trial, managed double-blind research with bigger pattern sizes are essential to assess the long-term security and efficacy of TMS for each sufferers and offspring uncovered in utero.

Emily Beydler, MD

References

1. Stewart DE, Vigod S. Postpartum Despair. N Engl J Med. 2016;375(22):2177-2186. doi:10.1056/NEJMcp1607649
2. Kim DR, Sockol LE, Sammel MD, Kelly C, Moseley M, Epperson CN. Elevated threat of hostile obstetric outcomes in pregnant ladies with despair. Arch Womens Ment Well being. 2013;16(6):475-482. doi:10.1007/s00737-013-0371-x
3. Wisner KL, Sit DKY, McShea MC, et al. Onset timing, ideas of self-harm, and diagnoses in postpartum ladies with screen-positive despair findings. JAMA Psychiatry. 2013;70(5):490-498. doi:10.1001/jamapsychiatry.2013.87
4. American Faculty of Obstetricians and Gynecologists (ACOG). ACOG committee opinion no. 757: screening for perinatal despair. Obstet Gynecol. 2018;132(5):e208-e212. doi:10.1097/AOG.0000000000002927
5. Battle CL, Zlotnick C, Pearlstein T, et al. Despair and breastfeeding: which postpartum sufferers take antidepressant medicines? Depress Nervousness. 2008;25(10):888-891. doi:10.1002/da.20299
6. George MS, Lisanby SH, Avery D, et al. Every day left prefrontal transcranial magnetic stimulation remedy for main depressive dysfunction: a sham-controlled randomized trial. Arch Gen Psychiatry. 2010;67(5):507-516. doi:10.1001/archgenpsychiatry.2010.46
7. Damar U, Lee Kaye H, Smith NA, Pennell PB, Rotenberg A. Security and tolerability of repetitive transcranial magnetic stimulation throughout being pregnant: A case report and literature assessment. J Clin Neurophysiol. 2020;37(2):164-169. doi:10.1097/WNP.0000000000000552
8. Guerrero Solano JL, Molina Pacheco E. Low-Frequency rTMS Ameliorates Akathisia Throughout Being pregnant. J Neuropsychiatry Clin Neurosci. 2017;29(4):409-410. doi:10.1176/appi.neuropsych.17030053
9. Kim DR, Wang E, McGeehan B, et al. Randomized managed trial of transcranial magnetic stimulation in pregnant ladies with main depressive dysfunction. Mind Stimulat. 2019;12(1):96-102. doi:10.1016/j.brs.2018.09.005
10. Ferrão YA, da Silva R de MF. Repetitive transcranial magnetic stimulation for the therapy of main despair throughout being pregnant. Rev Bras Psiquiatr. 2018;40(2):227-228. doi:10.1590/1516-4446-2017-2522
11. Martínez-Gras I, Jurado-Barba R, Sánchez-Pastor L, Rubio G, Prieto-Montalvo J. Antidepressant impact r TMS throughout being pregnant in a case of Main Despair Proof against Pharmacological Therapy. Actas Esp Psiquiatr. 2021;49(6):282-285.
12. Roman A, Ramirez A, Fox NS. Prevention of preterm start in twin pregnancies. American Journal of Obstetrics & Gynecology MFM. 2022;4(2S):100551. doi:10.1016/j.ajogmf.2021.100551
13. Janicak PG, O’Reardon JP, Sampson SM, et al. Transcranial magnetic stimulation within the therapy of main depressive dysfunction: a complete abstract of security expertise from acute publicity, prolonged publicity, and through reintroduction therapy. J Clin Psychiatry. 2008;69(2):222-232. doi:10.4088/jcp.v69n0208
14. Kim DR, Wang E. Prevention of supine hypotensive syndrome in pregnant ladies handled with transcranial magnetic stimulation. Psychiatry Res. 2014;218(1-2):247-248. doi:10.1016/j.psychres.2014.04.001
15. Suppa A, Huang YZ, Funke Okay, et al. Ten years of theta burst stimulation in people: established information, unknowns and prospects. Mind Stimulat. 2016;9(3):323-335. doi:10.1016/j.brs.2016.01.006
16. Diamond DM, Dunwiddie TV, Rose GM. Traits of hippocampal primed burst potentiation in vitro and within the awake rat. J Neurosci. 1988;8(11):4079-4088. doi:10.1523/JNEUROSCI.08-11-04079.1988
17. Blumberger DM, Vila-Rodriguez F, Thorpe KE, et al. Effectiveness of theta burst versus high-frequency repetitive transcranial magnetic stimulation in sufferers with despair (THREE-D): a randomised non-inferiority trial. Lancet. 2018;391(10131):1683-1692. doi:10.1016/S0140-6736(18)30295-2
18. Sylvén SM, Gingnell M, Ramirez A, Bodén R. Transcranial magnetic intermittent theta-burst stimulation for despair in being pregnant – A case collection. Mind Stimulat. 2020;13(6):1665-1667. doi:10.1016/j.brs.2020.09.013
19. Trevizol AP, Vigod SN, Daskalakis ZJ, Vila-Rodriguez F, Downar J, Blumberger DM. Intermittent theta burst stimulation for main despair throughout being pregnant. Mind Stimulat. 2019;12(3):772-774. doi:10.1016/j.brs.2019.01.003
20. Brock DG, Demitrack MA, Groom P, et al. Effectiveness of NeuroStar transcranial magnetic stimulation (TMS) in sufferers with main depressive dysfunction with postpartum onset. Mind Stimulat. 2016;9(5):e7. doi:10.1016/j.brs.2016.06.023
21. Yee A, Pedersen E, Koo M. A case collection of repetitive transcranial magnetic stimulation within the therapy of main despair throughout being pregnant. Mind Stimulat. 2022;15(2):373-375. doi:10.1016/j.brs.2022.01.021kim
22. Yee A, Pedersen E, Koo M. Repetitive Transcranial Magnetic Stimulation within the Therapy of Main Despair throughout Being pregnant: A Case Collection. Mind Stimulat. 2021;14(5):1407-1408. doi:10.1016/j.brs.2021.07.033
23. Cox EQ, Killenberg S, Frische R, et al. Repetitive transcranial magnetic stimulation for the therapy of postpartum despair. J Have an effect on Disord. 2020;264:193-200. doi:10.1016/j.jad.2019.11.069
24. Kim DR, Sockol L, Barber JP, et al. A survey of affected person acceptability of repetitive transcranial magnetic stimulation (TMS) throughout being pregnant. J Have an effect on Disord. 2011;129(1-3):385-390. doi:10.1016/j.jad.2010.08.027